Related Experiment Videos
New options in lipid management--can we extend the benefits of current therapy? Introduction
Antonio M Gotto1, Rodolfo Paoletti
1Weill Medical College of Cornell University, New York, NY, USA.
American Heart Journal
|December 18, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
LDL atherogenicity determined by size, density, oxidation, apolipoprotein(a), and electronegativity: an updated review.
Frontiers in cardiovascular medicine·2025
Atherosclerotic features in patients with heart failure.
Archives of medical science : AMS·2025
HDL-free cholesterol influx into macrophages and transfer to LDL correlate with HDL-free cholesterol content.
Journal of lipid research·2024
Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease.
Current atherosclerosis reports·2024
Serum opacity factor normalizes erythrocyte morphology in Scarb1-/- mice in an HDL-free cholesterol-dependent way.
Journal of lipid research·2023
The pathophysiology of excess plasma-free cholesterol.
Current opinion in lipidology·2023
Accuracy of Indirect Fick Method for Systemic Flow Calculation In Adults With A Fontan Circulation.
American heart journal·2026
Targeting SIRT2-mediated mitophagy to enhance ferroptosis: a novel mechanism of berberine action in non-small cell lung cancer.
Folia histochemica et cytobiologica·2026
Correction to: "Adherence to Daily Growth Hormone Therapy in Japan: Real-World Data from the Melon Nikki™ App and Device".
Journal of the Endocrine Society·2026
The Current Landscape and Prospects of iPSCs in BCMA-targeted Therapy for Multiple Myeloma.
Current stem cell research & therapy·2026